Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]
Tags : Pauline Pfirter
There is a merger in cruise brokerage. The two Swiss tourism companies e-hoi and Cruise Center also want to strengthen their bargaining power with the cruise lines. Business, down during the pandemic, is picking up again. Cruise Center, a Swiss company that has been selling cruises for over twenty years, has been acquired by the […]
Engimmune Therapeutics, a Swiss biotech company based in Basel developing novel T-cell receptor (TCR)-based therapeutics, has closed a CHF 15.5m seed financing round. The round was led by the investors Pureos Bio-ventures and Novo Holdings with incubation from BaseLaunch. The proceeds will be used to grow and develop T-cell receptor-based therapies for cancer treatments, expand […]
A group of investors advised by Rigeto Unternehmerkapital (“Rigeto”) has acquired 100% of the shares in Laser Beauté Med, headquartered in Sion with additional locations in Monthey and Visp. The oldest dermatology clinic in the Swiss Valais thus complements the presence of Clinique Matignon held by Rigeto investors. Growth was also underpinned by the opening […]
Alloy Therapeutics, a Boston based biotechnology ecosystem company, has entered into a definitive agreement to acquire deepCDR Biologics, a privately held Basel based developer of deep learning technology for antibody discovery and optimisation. Alloy will expand the Basel deepCDR site as a permanent Alloy research facility and will hire additional computational scientists and developers as it grows with the Alloy network. DeepCDR’s technology will strengthen Alloy […]
Vifor Pharma acquires the Swiss firm Inositec, a clinical stage biopharmaceutical company which is developing first-in-class treatments for unmet medical need. Through this acquisitions, Vifor Pharma will be spearheading the vascular calcification field to improve lives of more than 600,000 patients in U.S. and EU suffering from peripheral artery disease. Subject to the closing,that could […]
GlycoEra has successfully completed a CHF 45 million Series A financing round, co-led by 5AM Ventures, Roche Venture Fund and Sofinnova Partners. LimmaTech Biologics, from which GlycoEra was spun-out, also participated in this round. GlycoEra’s innovative CustomGlycan platform unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics for a broad range […]
Nautilus, an innovation specialist in home fitness, has entered into a definitive agreement to acquire Zurich based Vay, a company specialising in computer vision and AI technology solutions and the provider of motion detection and analysis. The financial terms of the transaction were not disclosed. With this acquisition, Vay’s proprietary technology, experience and highly technical skillset will be committed to the development […]
Tvs Motor Company, an Indian based global two-wheeler and three-wheeler manufacturer and the flagship company of the USD 8.5 billion TVS Group, has agreed on a long-term strategic a partnership with Ego Movement, a fast-growing Swiss e-mobility company, as a majority shareholder, in an all-cash deal through its Singapore Subsidiary Tvs Motor (Singapore). Ego Movement is a Swiss technology company providing mobility solutions […]
Anjarium Biosciences, a Swiss biotech company, recently closed a CHF 55.5 million (USD 61 million) Series A financing round, co-led by Gimv and Abingworth. The fundraising also saw significant participation from Omega Funds, Pfizer Ventures and surveyor capital (a citadel company). The proceeds from the series A financing will enable Anjarium to expand its team, develop its platform, and push serval therapeutic […]
